Literature DB >> 16740743

Barriers to efficient development of cancer therapeutics.

Philip S Schein1, Barbara Scheffler.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16740743     DOI： 10.1158/1078-0432.CCR-06-0329

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  11 in total

1.  Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.

Authors:  Jason W-L Eng; Chelsey B Reed; Kathleen M Kokolus; Rosemarie Pitoniak; Adam Utley; Mark J Bucsek; Wen Wee Ma; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

2.  Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.

Authors:  Ehud Segal; Huaizhong Pan; Liat Benayoun; Pavla Kopečková; Yuval Shaked; Jindřich Kopeček; Ronit Satchi-Fainaro
Journal:  Biomaterials       Date:  2011-03-22       Impact factor: 12.479

Review 3.  Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors:  James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 4.  Prostate cancer regulatory networks.

Authors:  Dario C Altieri; Lucia R Languino; Jane B Lian; Janet L Stein; Irwin Leav; Andre J van Wijnen; Zhong Jiang; Gary S Stein
Journal:  J Cell Biochem       Date:  2009-08-01       Impact factor: 4.429

5.  Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.

Authors:  Byoung Heon Kang; Janet Plescia; Ho Young Song; Massimiliano Meli; Giorgio Colombo; Kristin Beebe; Bradley Scroggins; Len Neckers; Dario C Altieri
Journal:  J Clin Invest       Date:  2009-02-23       Impact factor: 14.808

6.  Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancers.

Authors:  George A Vielhauer; Megan Swink; Nikhil K Parelkar; James P Lajiness; Amanda L Wolfe; Dale Boger
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

7.  The Impact of Housing Temperature-Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous System.

Authors:  Bonnie L Hylander; Jason W-L Eng; Elizabeth A Repasky
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

8.  Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study.

Authors:  Craig Reynolds; Elizabeth T Masters; Jenny Black-Shinn; Marley Boyd; Jack Mardekian; Janet L Espirito; Marc Chioda
Journal:  J Clin Med       Date:  2018-05-29       Impact factor: 4.241

9.  Challenging issues in molecular-targeted therapy.

Authors:  Zoheir Ezziane
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

Review 10.  Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.

Authors:  B H Kang; D C Altieri
Journal:  Oncogene       Date:  2009-08-03       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.